Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Regeneron Pharmaceuticals Inc (REGN) has a market cap of $79.87B with year-over-year revenue growth of +1.0%. Net margin stands at 31.4%. The stock trades at a P/E ratio of 17.7.
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, REGN posted revenue growth of +1.0% and trades at a P/E of 17.7.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.